Richard H. Scheller's most recent trade in 23andMe Holding Co - Ordinary Shares - Class A was a trade of 658,485 Class A Common Stock done . Disclosure was reported to the exchange on Aug. 26, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
23andMe Holding Co - Ordin... | Richard H. Scheller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 658,485 | 895,961 | - | 0 | Class A Common Stock | |
BridgeBio Pharma Inc | Richard H. Scheller | Director | 16 Feb 2023 | 3,196 | 12,783 | - | - | Restricted Stock Units | ||
BridgeBio Pharma Inc | Richard H. Scheller | Director | 16 Feb 2023 | 3,196 | 55,126 (0%) | 0% | - | Common Stock | ||
BridgeBio Pharma Inc | Richard H. Scheller | Director | 16 Feb 2023 | 1,304 | 53,822 (0%) | 0% | 12.6 | 16,483 | Common Stock | |
23andMe Holding Co - Ordin... | Richard H. Scheller | Director | Sale of securities on an exchange or to another person at price $ 3.24 per share. | 11 Nov 2022 | 18,421 | 72,388 | - | 3.2 | 59,684 | Class A Common Stock |
23andMe Holding Co - Ordin... | Richard H. Scheller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 14,633 | 90,809 | - | 0 | Class A Common Stock | |
23andMe Holding Co - Ordin... | Richard H. Scheller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2022 | 57,755 | 76,176 | - | 0 | Class A Common Stock | |
BridgeBio Pharma Inc | Richard H. Scheller | Director | 16 Aug 2022 | 3,196 | 50,941 (0%) | 0% | - | Common Stock | ||
BridgeBio Pharma Inc | Richard H. Scheller | Director | 16 Aug 2022 | 3,196 | 19,175 | - | - | Restricted Stock Units | ||
BridgeBio Pharma Inc | Richard H. Scheller | Director | 16 Aug 2022 | 1,101 | 49,840 (0%) | 0% | 11.1 | 12,199 | Common Stock | |
BridgeBio Pharma Inc | Richard H. Scheller | Director | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | ||
BridgeBio Pharma Inc | Richard H. Scheller | Director | 16 May 2022 | 3,195 | 49,055 (0%) | 0% | - | Common Stock | ||
BridgeBio Pharma Inc | Richard H. Scheller | Director | 16 May 2022 | 3,195 | 22,371 | - | - | Restricted Stock Units | ||
BridgeBio Pharma Inc | Richard H. Scheller | Director | 16 May 2022 | 1,310 | 47,745 (0%) | 0% | 6.7 | 8,829 | Common Stock | |
BridgeBio Pharma Inc | Richard H. Scheller | Director | 28 Feb 2022 | 25,566 | 25,566 | - | - | Restricted Stock Units | ||
BridgeBio Pharma Inc | Richard H. Scheller | Director | 02 Dec 2021 | 28,881 | 28,881 | - | - | Stock Option (right to buy) | ||
BridgeBio Pharma Inc | Richard H. Scheller | Director | 02 Dec 2021 | 16,685 | 16,685 | - | - | Stock Option (right to buy) | ||
23andMe Holding Co - Ordin... | Richard H. Scheller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2021 | 18,421 | 18,421 | - | 0 | Class A Common Stock, $0.0001 par value | |
BridgeBio Pharma Inc | Richard H. Scheller | Director, See Remarks | 04 Aug 2021 | 13,777 | 59,637 (0%) | 0% | 17 | 234,209 | Common Stock | |
BridgeBio Pharma Inc | Richard H. Scheller | Director, See Remarks | 04 Aug 2021 | 13,777 | 45,860 (0%) | 0% | 53.2 | 733,317 | Common Stock | |
BridgeBio Pharma Inc | Richard H. Scheller | Director, See Remarks | 04 Aug 2021 | 13,777 | 39,611 | - | - | Stock Option (Right to Buy) | ||
BridgeBio Pharma Inc | Richard H. Scheller | Director, Chairman of R&D | 17 Jun 2021 | 38,895 | 38,895 | - | - | Stock Option (right to buy) | ||
ORIC Pharmaceuticals Inc | Richard H. Scheller | Director | Sale of securities on an exchange or to another person at price $ 25.19 per share. | 20 May 2021 | 1,231 | 39,192 | - | 25.2 | 31,008 | Common Stock |
ORIC Pharmaceuticals Inc | Richard H. Scheller | Director | Sale of securities on an exchange or to another person at price $ 25.08 per share. | 20 May 2021 | 659 | 40,423 | - | 25.1 | 16,528 | Common Stock |
ORIC Pharmaceuticals Inc | Richard H. Scheller | Director | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 20 May 2021 | 100 | 39,092 | - | 25 | 2,500 | Common Stock |
ORIC Pharmaceuticals Inc | Richard H. Scheller | Director | Sale of securities on an exchange or to another person at price $ 25.38 per share. | 14 May 2021 | 4,615 | 44,382 | - | 25.4 | 117,117 | Common Stock |
ORIC Pharmaceuticals Inc | Richard H. Scheller | Director | Sale of securities on an exchange or to another person at price $ 25.34 per share. | 14 May 2021 | 2,800 | 41,082 | - | 25.3 | 70,958 | Common Stock |
ORIC Pharmaceuticals Inc | Richard H. Scheller | Director | Sale of securities on an exchange or to another person at price $ 25.06 per share. | 14 May 2021 | 500 | 43,882 | - | 25.1 | 12,530 | Common Stock |
ORIC Pharmaceuticals Inc | Richard H. Scheller | Director | Sale of securities on an exchange or to another person at price $ 25.16 per share. | 11 May 2021 | 300 | 49,200 | - | 25.2 | 7,548 | Common Stock |
ORIC Pharmaceuticals Inc | Richard H. Scheller | Director | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 11 May 2021 | 103 | 49,097 | - | 25 | 2,575 | Common Stock |
ORIC Pharmaceuticals Inc | Richard H. Scheller | Director | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 11 May 2021 | 100 | 48,997 | - | 25 | 2,500 | Common Stock |
ORIC Pharmaceuticals Inc | Richard H. Scheller | Director | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 01 Apr 2021 | 200 | 49,800 | - | 25 | 5,000 | Common Stock |
BridgeBio Pharma Inc | Richard H. Scheller | Director, See Remarks | 21 Dec 2020 | 45,473 | 45,860 (0%) | 0% | 65.5 | 2,977,699 | Common Stock | |
BridgeBio Pharma Inc | Richard H. Scheller | Director, See Remarks | 21 Dec 2020 | 14,928 | 91,333 (0%) | 0% | 64.8 | 967,437 | Common Stock | |
BridgeBio Pharma Inc | Richard H. Scheller | Director, See Remarks | 18 Dec 2020 | 27,105 | 109,156 (0%) | 0% | 65.0 | 1,761,589 | Common Stock | |
BridgeBio Pharma Inc | Richard H. Scheller | Director, See Remarks | 18 Dec 2020 | 2,895 | 106,261 (0%) | 0% | 65.8 | 190,432 | Common Stock | |
BridgeBio Pharma Inc | Richard H. Scheller | Director, See Remarks | 15 Dec 2020 | 29,277 | 53,388 | - | - | Stock Option (Right to Buy) | ||
BridgeBio Pharma Inc | Richard H. Scheller | Director, See Remarks | 15 Dec 2020 | 29,277 | 167,704 (0%) | 0% | 17 | 497,709 | Common Stock | |
BridgeBio Pharma Inc | Richard H. Scheller | Director, See Remarks | 15 Dec 2020 | 19,352 | 136,261 (0%) | 0% | 60.7 | 1,175,303 | Common Stock | |
BridgeBio Pharma Inc | Richard H. Scheller | Director, See Remarks | 15 Dec 2020 | 12,091 | 155,613 (0%) | 0% | 59.8 | 723,114 | Common Stock | |
BridgeBio Pharma Inc | Richard H. Scheller | Director, See Remarks | 16 Sep 2020 | 25,000 | 138,427 (0%) | 0% | 37.5 | 937,500 | Common Stock | |
BridgeBio Pharma Inc | Richard H. Scheller | Director, See Remarks | 02 Jun 2020 | 112,422 | 112,422 | - | - | Stock Option (right to buy) |